The lateral habenula (LHb) is a brain structure receiving inputs from limbic forebrain areas and innervating major midbrain monoaminergic nuclei. Evidence indicates LHb involvement in sleep control, reward-based decision making, avoidance of punishment, and responses to stress. Additional work has established that the LHb mediates negative feedback in response to aversive events. As a hallmark of drug addiction is the inability to limit drug use despite negative consequences, we hypothesize that LHb dysfunction may have a role in the lack of control over drug seeking. Here we examine the effects of LHb inactivation in control over drug seeking in several cocaine selfadministration (SA) paradigms in rats. We find that inhibition of the LHb with GABAergic agonists did not alter cocaine SA under progressive ratio or seeking/taking chained reinforcement schedules, or during punishment-induced suppression of cocaine-reinforced responding. In contrast, LHb inhibition increased cocaine seeking when the drug was not available in rats trained to discriminate its presence using an environmental cue. This effect of LHb inhibition was selective for cocaine, as it did not impair responding for sucrose reinforcement. The effect of LHb injection of GABA agonists was mimicked by intra-LHb muscarinic cholinergic (mACh) antagonist injection, and activation of mACh receptors excited a majority of LHb neurons in in vitro electrophysiology experiments. These results indicate that the LHb participates in the suppression of impulsive responding for cocaine through the activation of a cholinergic circuit, and they suggest that LHb dysfunction may contribute to impaired impulse control associated with drug addiction.
INTRODUCTION
The habenular complex constitutes a major relay between the forebrain and midbrain/hindbrain areas (Lecourtier and Kelly, 2007; Sutherland, 1982) . Two major subdivisions have been identified based on anatomical connectivity and cellular composition: the lateral and the medial habenula (LHb and MHb, respectively) . The LHb receives input from the limbic forebrain and basal ganglia and influences the activity of all major mid-brain monoaminergic nuclei. As LHb neurons are activated by negative outcomes, such as punishment, omission of an expected reward, or stimuli associated with negative events, it is suggested that a primary role is to process negative feedback associated with reward seeking behavior Hikosaka, 2007, 2009) . Consistent with this, activation of the LHb strongly inhibits dopamine (DA) neurons of the ventral tegmental area (VTA), a central component of the brain's reward pathway (Christoph et al, 1986; Ji and Shepard, 2007; Matsumoto and Hikosaka, 2007) . However, this inhibition of DA neurons is indirect, involving LHb-mediated excitation of inhibitory neurons in the rostromedial tegmental area (RMTg) , that broadly innervate the VTA DA neurons (Hong et al, 2011; Jhou et al, 2009) . As optogenetic activation of the LHb to RMTg pathway is aversive (Stamatakis and Stuber, 2012) , it is proposed that regulation of VTA DA activity by the LHb may underlie aversive effects of abused drugs (Lecca et al, 2014; Velasquez et al, 2014) . Consistent with this, LHb neurons are influenced by cocaine Jhou et al, 2013; Maroteaux and Mameli, 2012; Zuo et al, 2013) , and LHb activation is linked to the delayed aversive effects of cocaine (Jhou et al, 2013) , as well as to the negative, depressive-like state that occurs after chronic cocaine (Meye et al, 2015) . However, evidence for involvement of the LHb in ongoing drug-seeking behavior is limited (Lecca et al, 2014; Velasquez et al, 2014) . As the LHb is associated with the aversive properties of abused drugs (Jhou et al, 2013) and the suppression of behavior leading to negative outcomes (Hikosaka, 2010) , we hypothesize that it may be involved in regulating excessive or inappropriate drug-seeking behavior seen in addiction, where drug seeking persists despite its adverse consequences.
Previous studies have used animal behavioral paradigms to model diagnostic criteria of addiction in humans (BelinRauscent et al, 2016; Vanderschuren and Ahmed, 2013) . We have adapted rat cocaine SA paradigms (Deroche-Gamonet et al, 2004; Pelloux et al, 2007; Vanderschuren and Everitt, 2004) to examine whether LHb inhibition alters: (i) motivation to seek cocaine measured by break points in a progressive ratio (PR) schedule; (ii) the persistence of cocaine seeking during punishment of cocaine-reinforced responding; or (iii) the ability to control cocaine seeking during alternating periods of signaled availability and nonavailability (Go/NoGo task). We find that LHb inhibition increases cocaine seeking when cocaine is not available in a Go/NoGo paradigm, suggesting impaired control over drug seeking.
MATERIALS AND METHODS

Subjects
Male Long Evans rats (Charles River Laboratories, Wilmington, MA) weighing 300-400 g at the beginning of experiments were housed 2-3 per cage in facilities accredited by the American Association for the Accreditation of Laboratory Animal Care. They were maintained in a temperature-and humidity-controlled environment, under a reverse 12 h light/ dark cycle, with ad libitum food and water. All behavioral experiments were conducted during the dark cycle. The experimental procedures were approved by the Institutional Care and Use Committee of the National Institute on Drug Abuse, National Institutes of Health (Rockville, MD) and conducted in accordance with the Guide for the Care and Use of Laboratory Animals provided by the NIH and adopted by the NIDA Intramural Research Program.
Surgery
Rats were anesthetized with Equithesin (1% pentobarbital, 2% magnesium sulfate, 4% chloral hydrate, 42% propyleneglycol, 11% ethanol, 3 ml/kg i.p.), and a silastic catheter (ID: 0.020" OD: 0.037", Dow Corning, MI) was advanced 3.5 cm into the right jugular vein. The catheter terminated in an L-shaped steel tube mounted on top of the skull with cranioplastic cement and was secured with three stainless steel screws. In the same surgery, subjects were stereotaxically implanted with bilateral guide cannulae (C315, Plastics One, Roanoke, VA) aimed 1 mm dorsal to the LHb (AP: − 3.6, L: ± 0.6, V: − 3.6 mm relative to bregma). Following surgery, rats were housed individually and allowed to recover for at least 1 week prior to beginning experiments. Catheters were flushed after every training session with 0.1 ml of heparinized saline and 120 mg/ml cefazolin throughout the study.
Behavioral Procedures
Operant training took place in standard rat operant chambers (Med-Associates; St Albans, VT) placed inside sound attenuated boxes and equipped with a wall-mounted ventilation fan that provided background noise. A liquid swivel was mounted above the operant box to allow for connecting the IV catheters via PE50 tubing to an infusion pump located outside the chamber. The operant boxes were equipped with liquid dippers able to dispense 10 μl of a liquid solution to a magazine situated between two retractable levers. A light was located above each lever and a house light was placed on the opposite wall. Experiment 1. Rats were trained on a drug-seeking/taking chained schedule of cocaine self-administration (Zapata et al, 2010) in which they were required to press one lever (taking lever) to receive an i.v. cocaine infusion (0.75 mg/kg/ infusion) under a fixed ratio 1 (FR1) schedule (Zapata et al, 2010) . Following each response, the taking lever was retracted and the house light extinguished, followed by illumination of a cue light above the taking lever for 30 s. Animals were allowed to self-administer for a maximum of 40 infusions or 2 h. A chained schedule was then initiated in which every infusion cycle started with the insertion of a second lever, designated as the drug-seeking lever. The first lever press on the seeking lever after completion of a random interval (2 s average, RI2) resulted in retraction of the seeking lever and extension of the taking lever. The next press of the taking lever resulted in the cocaine infusion sequence. A time out of 30 s (TO30) was imposed after every infusion, after which another infusion cycle started with the presentation of the drug-seeking lever. Thus rats self-administered cocaine under an RI2/FR1:TO30 chained cocaine seeking/taking schedule. Each daily session lasted for 2 h or 10 infusions. The RI and TO components of the chained schedule were then increased in the following steps; RI2/FR1:TO30, RI20/ FR1:TO120, RI60/FR1:TO300, RI120/FR1:TO600. After stable responding on the final chained schedule was achieved, motivation for the drug was tested in two drugseeking/taking sessions alternating with two sessions in which only the taking lever was present and cocaine was available under a PR schedule.
Intracranial infusion of drugs was carried out using a microinjection cannula (C315I, Plastics One) inserted into the surgically implanted guide cannula and extended 1.0 mm below its tip. One of the solutions (0.5 μl) was then infused at a rate of 1 μl/min. The microinjection cannula was removed 1 min after the infusion, and animals were then placed in the operant boxes. In Experiment 1, rats received either phosphate-buffered saline (PBS) or Baclofen/Muscimol (B/M, 1 mM/0.1 mM) infused bilaterally in the LHb immediately before each test session, and each animal was tested with both PBS and B/M in each test condition, in a random order, according to a within-subject repeatedmeasures design.
During PR schedule sessions, only the drug-taking lever was present and each infusion resulted in an increase in the response ratio requirement for the next infusion (Richardson and Roberts, 1996) . The PR session was terminated when the animal failed to earn an infusion for 60 min. The last ratio completed was considered the breakpoint and was recorded as a measure of the animal's motivation to seek the drug. During the seeking/taking chained schedule sessions, the seeking responses were recorded as an additional measure of motivation for the drug thought to be less influenced by the non-specific motor enhancing effects of psychostimulants (Olmstead et al, 2000) .
After testing for drug motivation, rats were given three sessions on the RI120/FR1:TO600 chained schedule, followed by five punished sessions in which a response on the seeking lever resulted in either access to the taking lever or a scrambled foot shock delivered through the floor grid (50% probability, 0.6 mA × 0.5 s). One group of animals received PBS and the other B/M infusions in the LHb before each session in a between-subject design.
Experiment 2. Rats self-administered cocaine for 12 sessions (2 h or 40 infusions per session) on an FR1 Following testing on the Go-NoGo task, rats were retrained on an FR1 schedule and tested for sensitivity to punished responding for cocaine self-administration. They were divided into two groups, one group receiving bilateral LHb infusions of PBS and the other B/M prior to each session. Rats completed 3 baseline sessions, followed by 3 punished sessions in which cocaine infusions were accompanied by a scrambled foot shock 30% of the time (0.6 mA × 1 s).
Experiment 3. Groups of rats were trained to selfadminister cocaine in the Go-NoGo task. Then the effects of bilateral LHb infusion of one of the several neurotransmitter receptor antagonists was investigated. Each group received vehicle, B/M, or one of the two additional drugs on different test days in random order. These included the nonselective DA receptor antagonist flupenthixol (60 mM), the non-selective ionotropic glutamate receptor antagonist kynurenic acid (KA; 50 mM), a mixture of the 5-HT receptor antagonists ritanserin/ondansetron (5 mM/5 mM in 10% DMSO), the β-subunit-containing nicotinic acetylcholine (ACh) receptor antagonist mecamylamine (100 mM), or the non-selective muscarinic ACh (mACh) antagonist scopolamine (50 mM). The concentrations of all antagonists used in these experiments were chosen based on previous literature (de Mello Cruz et al, 2005; Murray et al, 2012; Santini et al, 2012; Sun et al, 2005; Tuerke et al, 2012; Wickham et al, 2013) .
Experiment 4
In vitro patch clamp electrophysiology. Brain slices were prepared from 10-week-old rats using a vibrating tissue slicer (Leica VT1000S) according to previously published protocols (Jhou et al, 2013) . Coronal slices (280 μm) containing the LHb were transferred to a holding chamber containing normal aCSF consisting of (mM): NaCl,126; KCl, 3.0; MgCl 2 , 1.5; CaCl 2 , 2.4; NaH 2 PO 4 , 1.2; glucose, 11.0; NaHCO 3 , 26, saturated with 95% O 2 /5% CO 2 , at 35°C for 20-25 min, maintained at room temperature. A brain slice was submerged in a low-volume (170 μl) recording chamber integrated into a fixed stage of an upright microscope and continuously perfused with warm (30-32°C) aCSF at 2 ml/ min using a peristaltic pump. The aCSF was warmed using an inline solution heater (TC-324B, Warner Instruments). Drugs were prepared as stock solutions in H 2 O and diluted in aCSF to the indicated concentrations. Visualization of LHb neurons was performed using differential interference contrast microscopy (Zeiss Axioskop). Recording electrodes (3-5 MΩ) were filled with (in mM): K-gluconate, 140; KCl, 5; HEPES, 10; EGTA, 0.2; MgCl 2 , 2; Mg-ATP, 4; Na 2 -GTP, 0.3; Na 2 -phosphocreatine, 10; pH 7.2 with KOH. Whole-cell voltage clamp recordings were performed using an Axopatch 200B (Molecular Devices), WinLTP software (WinLTP Ltd), and an A/D board (National Instruments PCI-6251) residing in a personal computer. Series resistance was monitored throughout recordings using brief hyperpolarizing steps (−10 mV, 200 ms), and cells demonstrating 410% change were excluded from analyses. Unless otherwise indicated, cells were voltage clamped at − 60 mV.
Drug application to LHb slices. Oxotremorine-M (Oxo-M) and scopolamine were purchased from Tocris Bioscience (Bristol, UK), dissolved at their final concentrations in normal aCSF and delivered to the brain slices via the peristaltic pump used for bath perfusion.
Experiment 5. A group of drug-naive rats was trained to respond for sucrose solution reward (10 μl of 20% sucrose) obtained via a dipper cup located in the food magazine. Lever presses on the active lever resulted in refilling of the dipper cup, followed by retraction of both levers and illumination of a cue light above the active lever for 5 s. Animals were trained under FR1 for a single 6-h session and then switched to 2 h long sessions or until 600 reinforcers were obtained. After 10 sessions, animals were switched to a Go-NoGo schedule (3 × 20 min intervals of food access interspersed with 3 × 20 min of sucrose unavailability, signaled by house light on or off, respectively). After stable responding was achieved (10-12 sessions), animals received bilateral infusions of either PBS or B/M in the LHb immediately before each daily session. Treatments were given over consecutive testing sessions in a random order in a within-subject design.
Histology
At the end of the experiment, cresyl violet (1% × 0.5 μl) was bilaterally infused through the guide cannulae. The animals were then killed, and their brains were removed and frozen on dry ice. Histological verification of the microinjection site was carried out in 30 μm cryostat frozen sections.
Data Analysis
Statistical analysis was conducted using one-or two-way repeated-measures ANOVA (GraphPad Software, La Jolla, CA). Main factors were training session/condition and treatment (LHb intracranial infusion). Differences among groups were assessed by Holms-Sidak's multiple comparison tests. An alpha value of po0.05 was considered statistically significant.
RESULTS
Histological examination of the injection sites showed that most infusions were made in the LHb, mainly in its medial aspect (Supplementary Figure S1) . Only animals with a confirmed LHb infusion site were included in the data analysis.
Experiment 1: Inactivation of the LHb Does not Alter Motivation for Cocaine or Punished Responding for Cocaine
The sequence for experiment 1 is shown in Figure 1a . The effect of LHb inhibition with B/M was examined on cocaineseeking behavior using a PR schedule of cocaine reinforcement. Bilateral B/M infusions did not significantly alter the maximum number of responses emitted to receive cocaine reinforcement (break point) (t (8) = 0.51, p = 0.62, paired t-test, Figure 1b) nor the number of responses in the seeking link of a seeking/taking chained schedule (t (8) = 1.4, p = 0.20, paired t-test, Figure 1c) .
We next evaluated whether LHb inhibition altered punished suppression of responding for cocaine by pairing seeking responses with foot shock in 50% of these trials. The punishment caused a significant decrease in subsequent seeking responses in both groups (main effect of punishment, F (7,56) = 17.70, po0.0001, ANOVA, Figure 1d ). However, inhibition of the LHb by B/M did not alter this effect (no main B/M treatment effect nor punishment by treatment interaction, F (1,8) = 0, p = 0.95 and F (7,56) = 0.48, p = 0.84, respectively). In an alternative punishment paradigm in which cocaine-taking responses were paired with foot shock, there was also decreased responding (F (5,50) = 10.0, po0.0001, ANOVA, Figure 1e) . However, the suppression of taking responses by punishment was also not altered by LHb inhibition (no main B/M treatment effect nor punishment by treatment interaction, F (1,10) = 2.80, p = 0.12 and F (5,50) = 0.26, p = 0.93, respectively). These data suggest that LHb inactivation does not alter the motivation to seek 
Experiment 2. Persistence of Cocaine Seeking Despite its Signaled Unavailability After LHb Inhibition
The inability to refrain from drug seeking is a hallmark of addiction that can be modeled in rodents by testing their ability to withhold responding during signaled periods when the drug is not available (Belin et al, 2008; Deroche-Gamonet et al, 2004) . We examined a role for the LHb in withholding responses for cocaine using a Go-NoGo task. During training, the percentage of incorrect responses emitted when cocaine was not available (NoGo) declined significantly from 50.4% on day 1 to 14.8% on day 12 (F (11,121) = 6.740, p = 0.0001, one way ANOVA, Figure 1f ). This resulted from decreased responding during NoGo periods (F (11,121) = 3.07, p = 0.04, one way ANOVA, Figure 1f) , with no change in responding during the Go intervals (F (11,121) = 1.68, p = 0.16). LHb inactivation with B/M disrupted this learned discrimination, resulting in significantly increased cocaine-seeking responses during the NoGo period (PBS = 21.4, 9.1-33.8; B/M = 41.8, 29.0-54.7, mean and 95% confidence intervals; t (11) = 3.061, p = 0.01, paired t-test, Figure 1g ). Detailed analysis revealed that B/M infusions enhanced responding during NoGo intervals, without significantly altering responding during Go intervals (significant main effect of Go-NoGo intervals, F (1,11) = 16.74, po0.002; and intervals × LHb infusion interaction, F (1,11) = 5.09, p = 0.045, two way ANOVA, Figure 2a) . We also observed a non-significant (main effect of LHb infusion, F (1,10) = 2.52, p = 0.14, two way ANOVA) trend toward increased responding on the inactive lever after B/M infusions ( Figure 2b ) during both Go and NoGo intervals (non-significant LHb infusion × intervals interaction, F (1,10) = 0.39, p = 0.55, two-way ANOVA). We next determined whether the effect of B/M on NoGo responding was present across all 3, 20 min periods in the test session. A three-way ANOVA with LHb infusion, Go-NoGo condition, and interval order as main factors revealed a significant Go-NoGo × LHb infusion interaction (F (1,132) = 5.08, p = 0.03), with no significant effect of interval order (F (2,132) = 0.88, p = 0.42) nor interval order × Go-NoGo × LHb infusion (F (2,132) = 0.11, p = 0.89), indicating that the enhanced cocaine-seeking responses during the NoGo intervals was present throughout the entire test session (Figure 2c ).
In the design above, all NoGo intervals were preceded by Go intervals in which cocaine was self-administered, perhaps leading to a confound in which the continued responding during NoGo periods resulted from cocaineassociated motor stimulation. To test this, the order of the Go-NoGo intervals was reversed, and sessions begun with a NoGo interval in which responding was measured before cocaine exposure. However, even with reversal of Go-NoGo order, responding for cocaine was still significantly elevated during NoGo trials (Figure 2d , significant Go-NoGo × LHb infusion interaction, F (1,132) = 14.5, po0.001, three-way ANOVA). Importantly, the interval order did not influence this effect (non-significant interval order effect, F (2,132) = 0.16, p = 0.85 nor interval order × GoNoGo × LHb infusion interaction (F (2,132) = 0.31, p = 0.73, Figure 2d ), indicating that exposure to cocaine during the Go intervals did not influence responding during NoGo intervals.
To control for diffusion of B/M into brain areas dorsal to the LHb, we implanted cannulae with tips located 1 mm above the LHb and tested the effects of either the GABA agonists or PBS on the GoNoGo task (n = 4). Infusions of B/M at this anatomical site did not significantly modify NoGo responding (t (3) = 0.58, p = 0.60, paired t-test, Supplementary Figure S2 ) compared with PBS, suggesting that diffusion of B/M up the infusion track to areas dorsal to the LHb did not account for the pattern of results observed with intra-LHb infusions.
Experiment 3. Go-NoGo Deficits are Mimicked by mACh Receptor Antagonism
We next investigated the neurotransmitter pathways that may underlie LHb control of cocaine seeking during NoGo periods. Local LHb blockade of ionotropic excitatory aminoacid receptors with KA (50 mM), or D1 and D2 DA receptors with flupenthixol (60 mM), did not alter cocaine seeking in the Go-NoGo procedure (Figure 3a) . Similarly, blockade of 5-HT 2 or 5-HT 3 receptors with ritanserin and ondansetron (5 mM each), respectively, did not alter responding (Figure 3b) . To investigate the involvement of cholinergic receptors, we tested the β-subunit nACh receptor antagonist mecamylamine (100 mM), which did not alter responding during NoGo intervals. In contrast to these negative results, intra-LHb infusion of the mACh receptor antagonist scopolamine (50 mM) significantly increased 
Experiment 4. mACh Receptor-Induced Excitation of LHb Neurons In Vitro
Our observation that B/M infusions into the LHb disrupt Go-NoGo responding for cocaine imply that increased activity of these neurons is required for this discrimination. This, together with the results with scopolamine, led us to hypothesize that mACh receptor activation excites LHb neurons. To test this, whole-cell patch clamp recordings were obtained from LHb neurons in brain slices and the effects of the mACh agonist Oxo-M on the amount of current necessary to hold the neuronal membrane potential (I hold ) at − 60 mV was examined. Most LHB neurons (50%) exhibited a decrease in I hold upon application of Oxo-M (10 μM; Figure 4) , which is consistent with the activation of monophasic depolarizing inward currents. The remaining Figure 4a and b), consistent with initial hyperpolarization followed by depolarization of the membrane potential, or they showed monophasic outward I hold responses (9.4%), consistent with hyperpolarization (Figure 4a and b) . The remaining neurons showed no response to Oxo-M (6.2%, Figure 4a and b). In additional experiments, the depolarizing outward currents were completely blocked by the mACh receptor antagonist scopolamine (10 μM; Figure 4c ). Collectively, these data indicate that the majority (84.4%) of LHb neurons are depolarized by mACh receptor activation, and this may account for the ability of scopolamine to disrupt NoGo responding for cocaine in vivo.
Experiment 5. LHb Inhibition Does Not Impair GoNoGo Responding for Sucrose Reinforcement
To determine whether disrupted Go-NoGo performance by LHb inactivation is specific to responding for cocaine, we examined its effect in animals trained in a Go-NoGo task for sucrose reward. Rats significantly decreased the percentage of non-reinforced sucrose-seeking responses during NoGo intervals from 17.4% of total responses to 9.0% over 12 sessions (F (11,110) = 3.64, p = 0.021, one-way ANOVA, Figure 5a ). However, LHb inhibition with B/M did not significantly alter the number of responses during NoGo periods in these sucrose-trained animals (main effect of LHb infusions, F (1,10) = 3.7, p = 0.08, two-way ANOVA, Figure 5b ). Moreover, there was also no change in responding during Go intervals during these infusions (Go-NoGo interval × LHb infusion interaction, F (1,10) = 1.92, p = 0.19, two-way ANOVA, Figure 5b) . As a result, LHb inactivation did not significantly alter the percentage of responses during the NoGo intervals (PBS = 7.6, 4.2 -11.1; B/M = 9.9, 6.6-13.9, mean and 95% confidence intervals; t (10) = 1.37, p = 0.20, paired t-test, Figure 5d ). There was also no effect of LHb inactivation on inactive lever responses (main LHb infusion effect, F (1,10) = 4.24, p = 0.07, two-way ANOVA, Figure 5c ), and no interval selectivity (Go-NoGo interval × LHb infusion interaction, F (1,10) = 0.44, p = 0.52, non-significant, twoway ANOVA, Figure 5c ). Therefore, unlike Go-NoGo responding for cocaine, LHb inhibition did not alter this discrimination for sucrose reinforcement.
DISCUSSION
Here we examine involvement of the LHb in the control of cocaine seeking using several behavioral models. LHb inhibition did not alter the motivation to seek and selfadminister cocaine measured by PR schedule break points nor with seeking responses in a seeking/taking chained schedule of cocaine reinforcement. Similarly, LHb inhibition did not alter punished suppression of cocaine seeking using foot shock administered either after the seeking response or during receipt of the drug. This distinction is important as coincident delivery of reward and punishment can diminish the effectiveness of punishment (Dickinson and Pearce, 1976) . As the LHb is involved in behavioral responses to negative outcomes, prediction errors (Hong et al, 2011; Hikosaka, 2007, 2009) , and other aversive events (Stamatakis and Stuber, 2012) , the lack of an effect of LHb inhibition on punished responding for cocaine in our study is somewhat surprising. However, our results agree with another study demonstrating that the LHb is not Lateral habenula and cocaine seeking A Zapata et al involved in punished suppression of responding for food reinforcement (Jean-Richard Dit Bressel and McNally, 2014) . Thus the LHb may participate in signaling negative outcomes but may not be essential for punishment-associated avoidance behavior. Despite the lack of involvement of the LHb in the motivation to seek cocaine and punished suppression of this behavior, we found that it is involved in withholding responses for cocaine in a Go-NoGo discrimination task. Importantly, rats highly trained to make this discrimination continued to seek cocaine when LHb activity was inhibited, despite its signaled non-availability. This change in behavior did not result from increased cocaine-evoked locomotor activity (Gifuni et al, 2012; Gill et al, 2013; Jean-Richard Dit Bressel and McNally, 2014; Lecourtier et al, 2008) , as increased cocaine seeking after LHb inhibition was limited to NoGo intervals, with no change observed during the Go intervals when cocaine is received. Also, reversing the order of Go-NoGo periods did not prevent deficits in response inhibition during the first NoGo interval, prior to cocaine exposure. Moreover, the lack of a selective increase in NoGo responses for sucrose also argues against generalized increases in activity as the explanation for these effects of LHb inhibition on NoGo responding.
Go-NoGo tasks are used to measure action inhibition and impulsiveness in humans and animals (Anker et al, 2008; Dougherty and Bjork, 2003; Lane et al, 2007; McDonald et al, 2003; Paine and Olmstead, 2004) , although it is also argued that deficits in performance on these tasks may reflect impairments in attention to and discrimination of stimuli defining the Go-NoGo intervals (Eagle et al, 2008) . However, LHb inactivation does not impair performance in operant tasks where subjects must choose between responses associated with reward size (Stopper and Floresco, 2013) or punishment (Jean-Richard Dit Bressel and McNally, 2014) or reward discrimination in a Y-maze (Baker et al, 2015) . Interestingly, intact LHb function appears necessary for appropriate response choice during more challenging cognitive tasks, such as repeated probabilistic reversal learning, or probabilistic discounting tasks, when repeated evaluations of reward outcomes and adjusted responses are required (Baker et al, 2015; Stopper and Floresco, 2013) . As the Go-NoGo task is argued to also include a choice component (Eagle et al, 2008) , and the rats in our study were required to evaluate the presence or absence of an environmental cue to respond appropriately within the same session, the LHb inhibitioninduced deficits in the task may result from an impairment in the ability to adjust response selection.
However, LHb inhibition did not impair performance in the Go-NoGo task when sucrose was used to reinforce behavior, suggesting that LHb inhibition does not lead to perceptual or attentional deficits nor to impaired discrimination or response selection in this task. Instead, the evidence favors the interpretation that LHb inhibition impaired the ability to withhold responses in cocaine-experienced rats. This also agrees with a previous study demonstrating that habenular lesions increase premature responding in a fivechoice serial reaction time task, another measure of impulse control (Lecourtier and Kelly, 2005) .
To determine which LHb neuronal pathways modulate Go-NoGo performance for cocaine, we examined the effects of blockers of several neurotransmitter systems. We found that intra-LHb blockade of glutamate receptors did not alter Go-NoGo behavior nor did infusion of the non-selective DA receptor antagonist flupenthixol. Similarly, although serotonergic inputs can excite LHb neurons via 5-HT 2 or 5-HT 3 receptors (Zuo et al, 2016) , we found that the antagonists ritanserin and ondansetron failed to alter NoGo cocaine seeking. The LHb receives ACh inputs from the dorsolateral tegmentum (Satoh and Fibiger, 1986) , the basal forebrain (Herkenham and Nauta, 1977) and the entopeduncular nucleus (Kha et al, 2000; Moriizumi and Hattori, 1992) , prompting our examination of a role for ACh in the Go-NoGo cocaine task. We found that β 4 -subunit-containing nACh receptors are not involved in regulating Go-NoGo cocaine seeking, as the antagonist mecamylamine did not alter this behavior. However, intra-LHb infusion of the mACh receptor antagonist scopolamine increased cocaineseeking responses during NoGo periods, in a manner that was indistinguishable from the effects of B/M. Although data regarding mACh receptor function in the LHb are scarce, acetylcholinesterase inhibitors can increase LHb glucose metabolism via mACh receptor activation (Bassant et al, 1993) , and M2 and M5 mACh receptor mRNA is detected at high and moderate levels in the LHb, respectively (Vilaró et al, 1990 (Vilaró et al, , 1992 . In electrophysiological studies, we also find that the mACh agonist Oxo-M generates either inward depolarizing or biphasic hyperpolarizing-depolarizing currents in most LHb neurons and that this is blocked by scopolamine. Together, these in vitro and in vivo pharmacological studies suggest that activation of mACh receptors excites neurons in the LHb, and this is involved in regulating impulsive responding for cocaine in the Go-NoGo task.
Cocaine has complex effects on LHb neuron activity, with some cells demonstrating excitation or inhibition upon cocaine exposure (Zhang et al, 2013) . Interestingly, some LHb neurons show biphasic responses to cocaine, characterized by early inhibition and delayed excitation, and this pattern temporally correlates with behavioral shifts in cocaine rewarding and aversive effects (Jhou et al, 2013) . This has inspired the hypothesis that the LHb mediates cocaine's acute aversive effects (Jhou et al, 2013) , as well as the negative, depression-like, emotional state associated with cocaine withdrawal (Meye et al, 2015) . However, LHb involvement in cocaine seeking is relatively unexplored. One study finds that electrical stimulation of the LHb increases or decreases operant responding for cocaine, depending on the frequency of the stimulation (Friedman et al, 2010) . However, as this was also observed in responding for sucrose reward, it is not selective for cocaine (Friedman et al, 2010) . These authors also report that LHb lesions do not alter cocaine responding but impair extinction of cocaine seeking. In contrast, another study reports no effect of LHb inactivation on extinction or cue-induced reinstatement of cocaine seeking (Gill et al, 2013) , which agrees with unpublished data from our laboratory.
Go-NoGo self-administration tasks are used to model loss of control over drug intake (Belin et al, 2008; DerocheGamonet et al, 2004) and loss of impulse control in food reinforcement (Anker et al, 2008; Paine and Olmstead, 2004; Paine et al, 2003) . Moreover, impulsivity is a trait associated with the development of addictive behavior (Anker et al, 2009; Belin et al, 2008; Economidou et al, 2009; de Wit, 2009) , and the development of an addictive behavioral phenotype in rats is predicted by early increased responding when the drug is unavailable (Deroche-Gamonet and Piazza, 2014) . In this context, our findings suggest that the LHb is involved in the withholding of responses for cocaine and that experience with this drug diminishes this control (de Wit, 2009 ). However, the inability to withhold responses following LHb inhibition does not appear to extend to sucrose self-administration, suggesting an impairment associated specifically with cocaine seeking. In this regard, we found that rats responding for sucrose acquired the discrimination between Go and NoGo periods more quickly than those trained for cocaine (compare Figure 1f and Figure 5a ), as they display much lower responding during initial NoGo intervals (17% NoGo responses for sucrose vs 51% for cocaine). Moreover, the sucrose-trained animals maintain lower levels of responding during NoGo intervals after the task has been learned (7-9% vs 15-20%, respectively). This is consistent with a greater difficulty in withholding responses for cocaine vs sucrose. This disparity may be related to prior exposure to cocaine, as earlier studies show that the bundle of LHb efferent axons known as the fasciculus retroflexus degenerates after high-dose, extended access psychostimulant exposure (Ellison, 1992; Lax et al, 2013) and that LHb metabolic activity decreases following acute and chronic exposure to cocaine (Hammer and Cooke, 1994; London et al, 1986) . Thus it is possible that the participation of the LHb in controlling responding for cocaine may be compromised by limited cocaine exposure, such as that used in our study, and that more extensive exposure may lead to further reductions in LHb output to downstream brain areas that are involved in regulating drug seeking. Thus damage to LHb efferents by psychostimulants may limit the inhibitory control that this brain structure exerts over drug intake, thereby driving compulsive drug seeking observed in addiction.
FUNDING AND DISCLOSURE
